A new version of ResearchHub is available.Try it now
Paper
0
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Authors
Jesús Miguel,Katja Weisel
Philippe Moreau,Martha Lacy,Kevin Song,Michel Delforge,Lionel Karlin,Hartmut Goldschmidt,Anne Banos,Albert Oriol,Adrián Alegre,Christine Chen,Michèle Cavo,Cármino Souza,Valentina Ivanova,Joaquín Martínez‐López,Andrew Belch,Antonio Palumbo,Stephen Schey,Pieter Sonneveld,Xin Yu,Lars Sternås,Christian Jacques,Mohamed Zaki,Meletios Dimopoulos
+23 authors
,Laurent GarderetJournal
Published
Sep 3, 2013
Show more
Save
Tip0
TipSave
